Munafa Stock Market Course + Intraday & FNO calls 
Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for NYSE stock GSK Glaxosmithkline Plc. Dated: 15 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange
If you are looking for Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 50.48 and Closed at: 49.12, which is -3.4% of previous session's close. It moved within a range of 49.07 and 50.50
The session was a Bearish session with an average volume of 6545200, which is 43.71% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 48.38 and resistance for tomorrow is 49.81
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 48.63, 48.13 resistance for tomorrow's hourly charts is 50.06, 50.99
10 Day SMA for Glaxosmithkline Plc (GSK) is 50.06 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 49.45 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 48.43 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 45.24 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 41.64 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 49.45 and 200 DMA is at 41.64, while 50 DMA and 100 DMA are at 48.43 and 45.24 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 49.45 and 20 EMA is at 49.53
| Date | Closing Price | 20 SMA | 20 EMA |
| 15 Thu Jan | 49.12 | 49.45 | 49.53 |
| 14 Wed Jan | 50.79 | 49.43 | 49.57 |
| 13 Tue Jan | 49.90 | 49.35 | 49.44 |
| 12 Mon Jan | 50.38 | 49.3 | 49.39 |
| 09 Fri Jan | 50.39 | 49.23 | 49.29 |
| 08 Thu Jan | 50.22 | 49.13 | 49.17 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 48.43 and 50 EMA is at 48.14
| Date | Closing Price | 50 SMA | 50 EMA |
| 15 Thu Jan | 49.12 | 48.43 | 48.14 |
| 14 Wed Jan | 50.79 | 48.39 | 48.1 |
| 13 Tue Jan | 49.90 | 48.31 | 47.99 |
| 12 Mon Jan | 50.38 | 48.25 | 47.91 |
| 09 Fri Jan | 50.39 | 48.16 | 47.81 |
| 08 Thu Jan | 50.22 | 48.03 | 47.7 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 45.24 and 100 EMA is at 45.9
| Date | Closing Price | 100 SMA | 100 EMA |
| 15 Thu Jan | 49.12 | 45.24 | 45.9 |
| 14 Wed Jan | 50.79 | 45.15 | 45.83 |
| 13 Tue Jan | 49.90 | 45.04 | 45.73 |
| 12 Mon Jan | 50.38 | 44.93 | 45.65 |
| 09 Fri Jan | 50.39 | 44.82 | 45.55 |
| 08 Thu Jan | 50.22 | 44.71 | 45.45 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 41.64 and 200 EMA is at 43.29
| Date | Closing Price | 200 SMA | 200 EMA |
| 15 Thu Jan | 49.12 | 41.64 | 43.29 |
| 14 Wed Jan | 50.79 | 41.58 | 43.23 |
| 13 Tue Jan | 49.90 | 41.52 | 43.15 |
| 12 Mon Jan | 50.38 | 41.47 | 43.08 |
| 09 Fri Jan | 50.39 | 41.41 | 43.01 |
| 08 Thu Jan | 50.22 | 41.35 | 42.94 |
Tenet Healthcare has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Tenet Healthcare, about 2.39% more returns!
Glaxosmithkline Plc has performed better than Teladoc Health in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Takeda Pharmaceutical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 12.01% more returns!
Resmed Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Resmed Inc, about 5.16% more returns!
Glaxosmithkline Plc has performed better than Abbvie Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Abbott Laboratories in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Avanos Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Avanos Medical, about 4.9% more returns!
Bristol Myers has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Bristol Myers, about 4.81% more returns!
Concord Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Concord Medical, about 9.04% more returns!
Chemed Corp has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Chemed Corp, about 5.58% more returns!
Charles River has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Charles River, about 13.19% more returns!
Quest Diagnostics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Quest Diagnostics, about 5.39% more returns!
Glaxosmithkline Plc has performed better than Emergent Biosolutions in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Johnson Johnson has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Johnson Johnson, about 3.57% more returns!
Laboratory Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Laboratory Corporation, about 4.27% more returns!
Mckesson Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Mckesson Corporation, about 3.82% more returns!
Glaxosmithkline Plc has performed better than Mednax Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Medtronic Plc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Pfizer Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Pfizer Inc, about 2.39% more returns!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Glaxosmithkline Plc in short term but the sell signal is initial and weak.
Glaxosmithkline Plc Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Glaxosmithkline Plc in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Glaxosmithkline Plc is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50 and Glaxosmithkline Plc GSK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
